Australia markets closed

Precigen, Inc. (PGEN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.4200+0.0200 (+1.43%)
At close: 04:00PM EDT
1.4300 +0.01 (+0.70%)
After hours: 07:57PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
6,225
6,225
26,909
14,267
103,178
Cost of revenue
6,119
6,119
6,339
5,745
55,513
Gross profit
106
106
20,570
8,522
47,665
Operating expenses
Research development
48,614
48,614
47,170
47,933
41,644
Selling general and administrative
40,415
40,415
48,006
51,994
91,704
Total operating expenses
89,029
89,029
95,176
99,927
133,348
Operating income or loss
-88,923
-88,923
-74,606
-91,405
-85,683
Interest expense
468
468
6,774
18,755
18,400
Total other income/expenses net
-10,208
-10,208
1,281
-978
-2,223
Income before tax
-96,362
-96,362
-79,966
-110,967
-103,855
Income tax expense
-458
-458
-189
-160
-82
Income from continuing operations
-95,904
-95,904
-79,777
-110,807
-103,773
Net income
-95,904
-95,904
28,317
-92,166
-170,521
Net income available to common shareholders
-95,904
-95,904
28,317
-92,166
-170,521
Basic EPS
-0.37
-0.39
0.14
-0.47
-1.02
Diluted EPS
-0.37
-0.39
0.14
-0.47
-1.02
Basic average shares
232,475
244,536
200,361
197,760
167,066
Diluted average shares
232,475
244,536
200,361
197,760
167,066